Triple Therapy
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
... that triple therapy represents the most potent pharmacological treatment available for patients with COPD with moderate-to-very severe airflow limitation, particularly those with an exacerbation ...
11
Efficacy of sequential therapy versus standard triple therapy versus quinolone-based triple therapy for eradication of Helicobacter pylori infection
... Endoscopic diagnosis in three groups was not significant with regards to presence of GERD, Gastric Ulcers, Duodenal Ulcers (p value>0.05) except for presence of erosive gastritis which was significantly higher in ...
5
<p>The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials</p>
... inhaler triple therapy with other treatments for adult patients with COPD (Table ...inhaler triple therapy, three studies 14 – 16 used FF/UMEC/VI and one study 17 used ...dual therapy ...
10
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
... Triple therapy (TT) consists of proton-pump inhibitor (PPI), clarithromycin, and amoxicillin has been consid- ered as standard first-line treatment for ...
7
Eradication of gastric Helicobacter spp by triple therapy in dogs
... that triple therapy for seven days using clarithromycin, amoxi- cillin and lansoprazole was effective in 100% of dogs (Anacleto et ...14-day triple therapy has an approximately 12% better cure ...
5
Current appraisal of single inhaler triple therapy in COPD
... point triple therapy reduced exacerbations by 25% vs VIL/UMEC and 15% vs ...comparing triple therapy to VIL/ UMEC was 32% for blood eosinophils of at least 150/ µ L and 12% for less than 150/ ...
7
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
... PPI-based triple therapy group than the culture-guided ...based triple therapy [11], the eradication rate was ...longer therapy is recom- mended to obtain a sufficient eradication rate ...
7
Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
... with triple therapy plus Probinul ...line therapy (omeprazole 1 mg/kg/d, amoxicillin 50 mg/kg/d and metronidazole 20 mg/kg/d), according to NASPGHAN guidelines, confirming the contribution of a high ...
5
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy
... PPI-based triple eradi- cation therapy in Korea was ...standard triple therapy has led to an increase of alternative ...second-line therapy (EBMT) during 1996–2004, at ...MEA ...
9
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials
... ICS/LABA therapy [1]. Until recently, inhaled triple therapy has required the administration of multiple inhalers, several times a day, with the most commonly ad- ministered multiple-inhaler ...
15
Symptomatic burden of COPD for patients receiving dual or triple therapy
... Patients and methods: Cross-sectional data from three Adelphi COPD surveys (2013–2016) conducted in the USA, Europe, Japan, and China were analyzed for patients with COPD and forced expiratory volume in 1 second #65% ...
12
Initiation of triple therapy maintenance treatment among patients with COPD in the US
... recommends triple therapy for only the group of patients with severe or very severe airflow limitation (GOLD Grade 3 or 4) who are highly symptomatic, and experiencing two or more exacerbations, or at least ...
11
<p>Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap</p>
... of triple therapy with glycopyrrolate (GLY) 50 µg/ day on budesonide/formoterol fumarate (BUD/FORM) 640/18 ...dual therapy period and 2.11 L (± 0.58 L) after the BUD/GLY/FORM triple ...
9
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
... A new class of drugs has been developed to do this, and in this systematic review we review the evidence for clinical effectiveness and safety of the new SGLT2 inhibitor drugs (dapagli fl ozin, formerly known under the ...
14
Sequential therapy versus standard triple therapy in Helicobacter pylori eradication
... The diseases include Iron deficiency anemia, Coronary artery disease, Cerebrovascular disease, Hypertension, Raynaud’s phenomena, Migraine headaches, Vomiting of pregnancy, Immune thrombocytopenic purpura, ...
8
Detection of Replication Competent Human Immunodeficiency Virus Type 1 (HIV 1) in Cultures from Patients with Levels of HIV 1 RNA in Plasma Suppressed to Less Than 500 or 50 Copies Per Milliliter
... We studied the frequency of positive PBMC cultures in a subset of subjects enrolled in a phase III clinical trial which compared triple therapy with indinavir and two nucleosides to dual-nucleoside ...
6
Click here to download PDF version of the article !
... (‘triple therapy’) enhances measures of platelet P2Y12 inhibition in patients with DM and CAD to a greater extent than standard dual anti-platelet therapy with aspirin and clopidogrel ...
5
Helicobacter pylori Infection in Recurrent Abdominal Pain in Childhood: Comparison of Diagnostic Tests and Therapy
... Nine patients who were confirmed to be infected with H pylon by culture, histologic analysis, HM-CAP EIA, CLO test, and PCR were treated with triple therapy.. This therapy consisted of a[r] ...
7
Triple antithrombotic therapy for atrial fibrillation and coronary stents
... 51—Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome– Thrombolysis in Myocardial Infarction 51; BMS—bare-metal stent; CABG—coronary ...
7
Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study
... OHA triple-therapy cohort may reflect greater HbA1c reductions and/or treatment regimens associated with higher hypoglycemia risk, patient numbers are compar- atively low in this cohort, and associated data ...
9